Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 7/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
| ▸ | CA1 | P00915 | 4/20 | 0.52 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.48 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.48 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.48 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.48 |
| ▸ | GPR84 | Q9NQS5 | 6/20 | 0.47 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | LCK | P06239 | 1/20 | 0.45 |
| ▸ | PPARD | Q03181 | 1/20 | 0.45 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.45 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3823186 | 1.00 | CA2 (0.59) | CA2MAPK1CA1GRIK1GRIK2 | |
| SCHEMBL19435808 | 0.98 | CA2 (0.57) | CA2MAPK1CA1GRIK1GRIK2 | |
| SCHEMBL19435811 | 0.98 | CA2 (0.57) | CA2MAPK1CA1GRIK1GRIK2 | |
| SCHEMBL342624 | 0.87 | CA2 (0.50) | CA2MAPK1CA1GRIK1GRIK2 | |
| SCHEMBL5611696 | 0.85 | CA2 (0.48) | CA2MAPK1CA1GRIK1GRIK2 | |
| Oxalic Acid SCHEMBL28551222 | 0.83 | CA2 (0.79) | CA2MAPK1CA1GRIK1GRIK2 | |
| SCHEMBL23829870 | 0.82 | CA2 (0.86) | CA2MAPK1CA1GRIK1GRIK2 | |
| SCHEMBL8606737 | 0.82 | CA2 (0.86) | CA2MAPK1CA1GRIK1GRIK2 | |
| SCHEMBL29946 | 0.82 | CA2 (0.86) | CA2MAPK1CA1GRIK1GRIK2 | |
| Oxalic Acid SCHEMBL17714532 | 0.81 | CA2 (0.76) | CA2MAPK1CA1GRIK1GRIK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1368057-B1 | METHOD TO ENHANCE THE IMMUNOGENICITY OF AN ANTIGEN | TORREY PINES INST (US) | 2009-08-26 | — | — | EP | disclosed |
| US-7229621-B2 | Method to enhance the immunogenicity of an antigen | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES (US) | 2007-06-12 | — | — | US | disclosed |
| EP-1071411-B1 | TOPICAL IMMUNOSTIMULATION TO INDUCE LANGERHANS CELL MIGRATION | TORREY PINES INST (US) | 2007-03-14 | — | — | EP | disclosed |
| EP-1071411-A4 | TOPICAL IMMUNOSTIMULATION TO INDUCE LANGERHANS CELL MIGRATION | TORREY PINES INST (US) | 2004-12-08 | — | — | EP | disclosed |
| EP-1368057-A2 | METHOD TO ENHANCE THE IMMUNOGENICITY OF AN ANTIGEN | Lancell, Llc (US) | 2003-12-10 | — | — | EP | disclosed |
| WO-2002074332-A2 | METHOD TO ENHANCE THE IMMUNOGENICITY OF AN ANTIGEN | LANCELL, LLC (US) | 2002-09-26 | — | — | WO | disclosed |
| US-6210672-B1 | TOPICAL ADMINISTRATION OF AN ANTIGEN OR A PORTION THEREOF IN CONJUNCTION WITH AN ENHANCER OF SKIN PENETRATION AND AN INDUCER OF LANGERHANS CELL MIGRATION. | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES | 2001-04-03 | — | — | US | disclosed |
| EP-1071411-A1 | TOPICAL IMMUNOSTIMULATION TO INDUCE LANGERHANS CELL MIGRATION | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES (US) | 2001-01-31 | — | — | EP | disclosed |
| WO-1999053912-A1 | TOPICAL IMMUNOSTIMULATION TO INDUCE LANGERHANS CELL MIGRATION | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES (US) | 1999-10-28 | — | — | WO | disclosed |